Elucirem
Payments companies reported to CMS as associated with Elucirem. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Elucirem, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Elucirem
These are the largest totals companies reported as associated with Elucirem. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lawrence Tanenbaum | New York, NY | Diagnostic Radiology | $194,072.77 |
| Jeffrey Maki | Aurora, CO | Diagnostic Radiology | $164,594.56 |
| Bachir Taouli | New York, NY | Diagnostic Radiology | $91,912.71 |
| Donna Roberts | Charleston, SC | Diagnostic Radiology | $78,516.49 |
| Aashim Bhatia | Philadelphia, PA | Diagnostic Radiology | $18,091.75 |
| Laurie Loevner | Philadelphia, PA | Neuroradiology | $8,836.99 |
| Daniel Ginat | Chicago, IL | Diagnostic Radiology | $7,637.38 |
| Blake Johnson | St Louis Park, MN | Diagnostic Radiology | $7,289.42 |
| Kara-Lee Pool | Torrance, CA | Diagnostic Radiology | $7,200.00 |
| Daniel Ludwig | Saint Louis, MO | Diagnostic Radiology | $7,142.29 |
Prescribed Elucirem?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.